PrahladRaninga

I am a researcher working on breast and ovarian cancer

[PrahladRaninga @RaningaPrahlad]

@jjyerbury @nhmrc What if we are putting two Grant's but both are for Cure Cancer Australia only?

[PrahladRaninga @RaningaPrahlad]

@VittorioOrazio Many congratulations Orazio..

[PrahladRaninga @RaningaPrahlad]

My new paper showing that a new proteasome inhibitor Marizomib suppresses triple-negative breast cancer primary growth, and lung and brain metastases. https://t.co/Hm1IO61qRO #Theranostics
Thank you @CureCancerAu for funding this work.

[PrahladRaninga @RaningaPrahlad]

@TashbibK Congratulations Tash...

[PrahladRaninga @RaningaPrahlad]

@HardeepSPuri @airindiain @MoCA_GoI @AAI_Official @DelhiAirport @MEAIndia @ITBP_official We all Indians should support Air India who always help us in crisis.

[PrahladRaninga @RaningaPrahlad]

@jyotsnabatra @katejonesqld @AdvanceQld @CureCancerAu @qut_ihbi @QUT @MargaretSheil @manjujehu @TRI_info @MetSthHealth Many congratulations Jyotsna!

[PrahladRaninga @RaningaPrahlad]

@elaine_sanij Many congratulations Elaine!

[PrahladRaninga @RaningaPrahlad]

Thank you #ANZGOG for supporting my work and thank you #QIMRBerghofer ...

[QIMR Berghofer @QIMRB_Institute]

During #OvarianCancerAwarenessMonth we acknowledge Dr @RaningaPrahlad's work at #QIMRBerghofer researching a new approach to targeted therapy in advanced #ovariancancer patients thanks to @anzgog grant.

[PrahladRaninga @RaningaPrahlad]

Extremely glad to receive the Fund for New Research grant from ANZGOG for my ovarian cancer research. Thank you @anzgog and @QIMRBerghofer for a continued support.

[PrahladRaninga @RaningaPrahlad]

Presenting my work today on synergistic anti-cancer activity of auranofin and anti-PD-L1 combination therapy in #TNBC at the European Socirty for Medical Oncology Congress in Spain. Glad to receive positive feedback from fellow researchers! Thank you @EACRnews for travel award.

[PrahladRaninga @RaningaPrahlad]

Our recent paper on using #goldcompounds to treat multiple myeloma. Thank you @CureCancerAu, @QIMRBerghofer and @Griffith_Uni supporting my research. https://t.co/LR9lkVt6bi

[PrahladRaninga @RaningaPrahlad]

@Dr_MarkAdams @IASLC @TRI_info @qut_ihbi @RealHealthM @QUTmedia Congratulations Mark! Well deserved!

[PrahladRaninga @RaningaPrahlad]

Our recent paper on using #goldcompounds to treat multiple myeloma. Thank you @CureCancerAu, @QIMRBerghofer and @Griffith_Uni supporting my research. https://t.co/LR9lkVt6bi

[PrahladRaninga @RaningaPrahlad]

@CureCancerAu Thank you @CureCancerAu

[PrahladRaninga @RaningaPrahlad]

We have recently published our findings on the anti-cancer activity of an FDA-approved drug in combination with anti-PD-L1 therapy for triple-negative breast cancer. We thank @CancerAustralia and @CureCancerAu for funding this work and @QIMRBerghofer. https://t.co/Uf6JgJ4J9E

[Cure Cancer @CureCancerAu]

Triple-negative #breastcancer is very aggressive & lethal with poor prognosis. Only 25% TNBC patients respond to conventional #chemotherapy. Prahlad Raninga @QIMRBerghofer shows he is using a novel proteasome inhibitor to treat primary & #metastatic triple-negative breast cancer